High-flow nasal therapy (HFNT) was introduced into clinical practice in the early 2000s as a form of noninvasive respiratory support (NIRS). During the last 20 years, a growing body of evidence has shown the value of this intervention in the management of acute and chronic respiratory failure.

Crimi, C., Cortegiani, A. (2023). High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future. JOURNAL OF CLINICAL MEDICINE, 12(7) [10.3390/jcm12072666].

High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future

Cortegiani, Andrea
2023-04-03

Abstract

High-flow nasal therapy (HFNT) was introduced into clinical practice in the early 2000s as a form of noninvasive respiratory support (NIRS). During the last 20 years, a growing body of evidence has shown the value of this intervention in the management of acute and chronic respiratory failure.
3-apr-2023
Crimi, C., Cortegiani, A. (2023). High-Flow Nasal Therapy in Acute and Chronic Respiratory Failure: Past, Present, and Future. JOURNAL OF CLINICAL MEDICINE, 12(7) [10.3390/jcm12072666].
File in questo prodotto:
File Dimensione Formato  
jcm-12-02666 (1).pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 199.02 kB
Formato Adobe PDF
199.02 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/586275
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact